Performance analysis of Fennec Pharmaceuticals (FENC)
Annual Return
Over the past 3 years, FENC has had an average annual return of +6.69%, underperforming the benchmark SPY, which returned +22.77% annual.
Over the past 5 years, FENC has had an average annual return of +6.20%, underperforming the benchmark SPY, which returned +14% annual.
Over the past 10 years, FENC has had an average annual return of +15.39%, underperforming the benchmark SPY, which returned +15.53% annual.
Since Sep 9, 2014, FENC has had an average annual return of +10.51%, underperforming the benchmark SPY, which returned +14% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +29.61% | +21.84% | -43.67% | +16.88% | +118.19% | -40.94% | +14.79% | +1.72% | -36.33% | +368.53% | +22.60% | -35.16% |
| 2014 | |||||||||||
| -12.94% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -1.43% | +11.86% | -27.56% | +5.53% | +53.01% | +0.50% | +29.61% | ||||||
| 2025 | +2.85% | +8% | -13.25% | -0.82% | +34.43% | +2.22% | -1.45% | +8.44% | +5.52% | -12.39% | -0.12% | -5.98% | +21.84% |
| 2024 | -10.96% | -5.21% | +17.42% | -17.45% | -26.14% | -9.89% | +5.90% | -13.91% | -10.24% | -12.80% | +38.99% | +4.29% | -43.67% |
| 2023 | +4.27% | -10.09% | -7.55% | -1.56% | -7.45% | +16.49% | +0.91% | -8.42% | -7.97% | -8.39% | +25% | +30.46% | +16.88% |
| 2022 | +5.69% | +20.21% | +0.18% | +3.12% | -1.12% | -2.28% | +19.71% | +4.79% | +15.71% | +8.64% | +10.91% | -1.64% | +118.19% |
| 2021 | -3.36% | +1.67% | -15.16% | +0.65% | +17.92% | -1.09% | -10.70% | +21.66% | +18.94% | -1.70% | -52.59% | +0.23% | -40.94% |
| 2020 | +2.62% | +2.91% | -13.33% | +5.22% | +18.40% | +12.84% | +1.14% | -35.11% | +10.58% | +24.75% | +3.44% | -4.73% | +14.79% |
| 2019 | +4.86% | -0.60% | -27.07% | -8.25% | -15.73% | +6.67% | +17% | -8.12% | +11.86% | +11.02% | +17.24% | +3.66% | +1.72% |
| 2018 | -11.68% | +4.29% | +31.04% | +3.35% | -7.68% | -9.53% | -11.88% | +3.48% | -13.87% | -11.22% | -7.97% | -4.78% | -36.33% |
| 2017 | -6.26% | +34.68% | +14.81% | +14.80% | +5.37% | +69.33% | -7.87% | +19.66% | +58.43% | -14.43% | +2.11% | +3.41% | +368.53% |
Drawdown analysis of Fennec Pharmaceuticals (FENC)
The maximum drawdown for the FENC was -91.43%, occurring on Nov 27, 2015. Recovery took 338 trading sessions.
The current FENC drawdown is -30.35%.
Since Sep 9, 2014 FENC has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 2 times
- 30% or more: 5 times
- 20% or more: 6 times
- 10% or more: 7 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -91.43% | Sep 30, 2014 | 293 | Nov 27, 2015 | 338 | Apr 3, 2017 | 631 |
| -76.97% | Apr 9, 2018 | 296 | Jun 12, 2019 | Ongoing | Ongoing | Ongoing |
| -33.12% | Oct 12, 2017 | 82 | Feb 9, 2018 | 35 | Apr 3, 2018 | 117 |
| -31.72% | Sep 9, 2014 | 9 | Sep 22, 2014 | 6 | Sep 30, 2014 | 15 |
| -31.35% | Apr 12, 2017 | 18 | May 9, 2017 | 21 | Jun 8, 2017 | 39 |
| -20.12% | Jul 6, 2017 | 15 | Jul 27, 2017 | 21 | Aug 25, 2017 | 36 |
| -13.68% | Apr 3, 2017 | 1 | Apr 4, 2017 | 3 | Apr 7, 2017 | 4 |
| -9.02% | Sep 14, 2017 | 11 | Sep 29, 2017 | 9 | Oct 12, 2017 | 20 |
| -9.00% | Jun 13, 2017 | 5 | Jun 20, 2017 | 1 | Jun 21, 2017 | 6 |
| -6.25% | Aug 25, 2017 | 2 | Aug 29, 2017 | 7 | Sep 8, 2017 | 9 |
| -2.68% | Jun 30, 2017 | 1 | Jul 3, 2017 | 1 | Jul 5, 2017 | 2 |
| -0.99% | Jun 21, 2017 | 3 | Jun 26, 2017 | 1 | Jun 27, 2017 | 4 |
| -0.08% | Apr 3, 2018 | 1 | Apr 4, 2018 | 1 | Apr 5, 2018 | 2 |